Jyong Biotech Ltd. Ordinary Shares
NASDAQ: MENS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Fu-Feng Kuo
- Employees
- 31
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2025
- Market cap
- $144.5M
- Website
- https://www.jyongbio.com/
Loading MENS…
Loading profile data…Frequently asked questions about MENS
What does Jyong Biotech Ltd. Ordinary Shares (MENS) do?
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is acti...
Where does MENS trade?
Jyong Biotech Ltd. Ordinary Shares (MENS) trades on the NASDAQ Global Select.
What sector is MENS in?
Jyong Biotech Ltd. Ordinary Shares (MENS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jyong Biotech Ltd. Ordinary Shares?
Fu-Feng Kuo is the chief executive officer of Jyong Biotech Ltd. Ordinary Shares (MENS).
Where is Jyong Biotech Ltd. Ordinary Shares headquartered?
Jyong Biotech Ltd. Ordinary Shares is headquartered in Taiwan.
Does MENS pay a dividend?
Jyong Biotech Ltd. Ordinary Shares (MENS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MENS go public?
Jyong Biotech Ltd. Ordinary Shares (MENS) completed its initial public offering in 2025.